ASV

DELTA-(L-ALPHA-AMINOADIPOYL)-L-CYSTEINYL-D-VINYLGLYCINE

Created:	2003-02-03
Last modified:	2011-06-04

Find Related PDB Entry
4 entries where ASV is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	44
Chiral Atom Count	3
Bond Count	43
Aromatic Bond Count	0

2D diagram of ASV

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	DELTA-(L-ALPHA-AMINOADIPOYL)-L-CYSTEINYL-D-VINYLGLYCINE
Systematic Name (OpenEye OEToolkits)	(2S)-2-amino-6-[[(2R)-1-[[(2R)-1-hydroxy-1-oxo-but-3-en-2-yl]amino]-1-oxo-3-sulfanyl-propan-2-yl]amino]-6-oxo-hexanoic acid
Formula	C₁₃ H₂₁ N₃ O₆ S
Molecular Weight	347.387
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(NC(\C=C)C(=O)O)C(NC(=O)CCCC(C(=O)O)N)CS
SMILES	CACTVS	3.341	N[CH](CCCC(=O)N[CH](CS)C(=O)N[CH](C=C)C(O)=O)C(O)=O
SMILES	OpenEye OEToolkits	1.5.0	C=CC(C(=O)O)NC(=O)C(CS)NC(=O)CCCC(C(=O)O)N
Canonical SMILES	CACTVS	3.341	N[C@@H](CCCC(=O)N[C@@H](CS)C(=O)N[C@H](C=C)C(O)=O)C(O)=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	C=C[C@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)CCC[C@@H](C(=O)O)N
InChI	InChI	1.03	InChI=1S/C13H21N3O6S/c1-2-8(13(21)22)16-11(18)9(6-23)15-10(17)5-3-4-7(14)12(19)20/h2,7-9,23H,1,3-6,14H2,(H,15,17)(H,16,18)(H,19,20)(H,21,22)/t7-,8+,9-/m0/s1
InChIKey	InChI	1.03	JJJCGQKXGIRXKN-YIZRAAEISA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB03427
Name	delta-(L-alpha-Aminoadipoyl)-L-cysteinyl-D-vinylglycine
Groups	experimental
Synonyms	delta-(L-alpha-Aminoadipoyl)-L-cysteinyl-D-vinylglycine

Related Resource References

Resource Name	Reference
PubChem	6398414

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.